CD163 might not be the most exciting name in the world, but behind it lies one of the body's most important defense receptors ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...

Cell membrane proteins hide secret gateways that can be used to modify cell behavior. This has been demonstrated in a study ...

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

New research indicates GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, ...

In an effort to find new treatments for castrate-resistant prostate cancer, a TTUHSC research team led by Srinivas Nandana, ...

Shares of Portage Biotech Inc. more than doubled in after-hours trading on Thursday as the company reported promising ...

Austin Wells se convirtió en el primer receptor en conectar un jonrón al abrir un juego del día inaugural, Anthony Volpe también se fue profundo y los ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant prostate cancer previously treated with ...